Sign In
to Vote &
Create Storyboards.
 
Scientists discovered that certain cancer cells use a low-level activation of a DNA-dismantling enzyme-normally seen in cell death-to survive treatment. Instead of dying, these persister cells leverage this sublethal signal to regrow. Because the mechanism is non-genetic, it appears much earlier than typical resistance mutations. Targeting this enzyme could help stop tumors from returning.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard